Your browser doesn't support javascript.
loading
RPPA: Origins, Transition to a Validated Clinical Research Tool, and Next Generations of the Technology.
Petricoin, Emanuel; Wulfkuhle, Julie; Howard, Marissa; Pierobon, Marielena; Espina, Virginia; Luchini, Alessandra; Liotta, Lance A.
  • Petricoin E; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
  • Wulfkuhle J; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
  • Howard M; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
  • Pierobon M; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
  • Espina V; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
  • Luchini A; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
  • Liotta LA; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA. liotta.lance@gmail.com.
Adv Exp Med Biol ; 1188: 1-19, 2019.
Article en En | MEDLINE | ID: mdl-31820380
ABSTRACT
RPPA technology has graduated from a research tool to an essential component of clinical drug discovery research and personalized medicine. Next generations of RPPA technology will be a single clinical instrument that integrates all the steps of the workflow.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis por Matrices de Proteínas / Proteómica / Medicina de Precisión Tipo de estudio: Prognostic_studies Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis por Matrices de Proteínas / Proteómica / Medicina de Precisión Tipo de estudio: Prognostic_studies Idioma: En Año: 2019 Tipo del documento: Article